This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
We have grown from $10 billion to $80 billion. India is not too far from reaching the league of top-10 countries in Biotech's global ecosystem”
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Subscribe To Our Newsletter & Stay Updated
